{"blog": [], "keywords": [{"value": "Pain-Relieving Drugs", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Drug Abuse and Traffic", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "United States Politics and Government", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Lobbying and Lobbyists", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Drug Enforcement Administration", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "CVS Caremark Corporation", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Walgreen Co.", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "House of Representatives", "name": "organizations", "rank": "8", "is_major": "N"}, {"value": "Senate", "name": "organizations", "rank": "9", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/05/19/us/politics/opioid-dea-addiction.html", "document_type": "article", "byline": {"person": [{"lastname": "HARRIS", "firstname": "Gardiner", "role": "reported", "organization": "", "rank": 1}, {"lastname": "HUETTEMAN", "firstname": "Emmarie", "role": "reported", "organization": "", "rank": 2}], "original": "By GARDINER HARRIS and EMMARIE HUETTEMAN"}, "type_of_material": "News", "multimedia": [], "section_name": "U.S.", "word_count": "1228", "source": "The New York Times", "subsection_name": "Politics", "lead_paragraph": "The House and the Senate have whipsawed between ensuring access to narcotic painkillers and addressing the addiction epidemic linked to those drugs.", "pub_date": "2016-05-18T22:45:54Z", "news_desk": "National", "headline": {"print_headline": "Congress Mixes Opioid Messages", "main": "Actions by Congress on Opioids Haven\u2019t Included Limiting Them"}, "print_page": "1", "snippet": "The House and the Senate have whipsawed between ensuring access to narcotic painkillers and addressing the addiction epidemic linked to those drugs.", "_id": "573cf0a438f0d81236fa7f62", "slideshow_credits": null, "abstract": "Congress has yet to strike right balance between opioid access for those in need and restrictions to prevent abuse of prescription pain killers; for now, focus seems to be on treatment of addiction while allowing opioid prescriptions to remain accessible, move that benefits pharmacies, drug makers and consumers."}